Pfizer announced that its combination therapy of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) has demonstrated ...

A summary of current health news, including a Nipah virus death in Kerala, an mpox case rise in Uganda, and Pfizer's efforts ...

Pfizer’s Braftovi+Mektovi shows long-term clinically meaningful response in patients with BRAF V600E-mutant metastatic NSCLC: New York Monday, September 16, 2024, 10:00 Hrs [IST ...

Pfizer (NYSE: PFE) released longer-term follow-up results from the Phase II single-arm PHAROS clinical trial evaluating the efficacy and safety of Braftovi (encorafenib) in combination with Mektovi ...

A summary of current health news including Walgreens settling fraud charges, FDA approval for Eli Lilly's eczema drug, links ...

Combining encorafenib (Braftovi) and cetuximab (Erbitux; EC) with the chemotherapy regimen of fluorouracil, leucovorin, and irinotecan (FOLFIRI) was tolerable and showed promising antitumor activity ...

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and ...

Algeria's constitutional court has certified President Abdelmadjid Tebboune’s landslide victory in last weekend’s election ...

Pfizer Inc. (PFE) announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy ...

A new attempt has begun to try to salvage an oil tanker burning in the Red Sea after attacks by Yemen’s Houthi rebels. The EU ...